ABCB1 and cancer: Nanosized carriers loaded with drugs have proven therapeutic benefits for different types of cancers, due to higher antitumor efficiency, specific delivery of drug to the target organ, greater cytotoxicity, and inhibition of P-glycoprotein-dependent multidrug resistance [248].